drug

ciclesonide

Marketedupdated 2mo ago

by Covis Pharmaceuticals Inc (Inactive)

Approved

community read0 votes

indications

investigational

Asthma

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Patent cliff

source: FDA Orange Book

first barrier falls

Feb 1, 2028

~1.6 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (4)

Feb 1, 2028method-of-use (U-1355)US 83712921.6y
Feb 1, 2028method-of-use (U-1356)US 83712921.6y
Feb 1, 2028method-of-use (U-1357)US 83712921.6y
Feb 1, 2028method-of-use (U-1355)US 83712921.6y

Data sources

ClinicalTrials.gov

last refreshed 42m ago

Found something off?

Trials studying ciclesonide

phase3PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -Vcompletedn=2,240